Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients with Chronic HCV Infection

Impact of Hepatic Steatosis on Fibrosis and Treatment Response in Chronic Hepatitis B: a Longitudinal Cohort Study

Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients

IMPACT OF OBESITY ON SUSTAINED VIROLOGIC RESPONSE TO SOFOSBUVIR BASED REGIMENS IN THE EGYPTIAN CHRONIC HEPATITIS C PATIENTS

The Effect of Direct Acting Antiviral Therapy for Hepatitis C- Virus Infected Egyptian Patients on Changes in the Parameters of Liver Fibrosis Progression

Effect of Treatment With Direct Acting Antivirals on Glucose and Lipid Metabolism in Egyptian Patients With Chronic Hepatitis C

Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients

Effect of Direct-Acting Antiviral Therapy on Lipid Profile in Egyptian Patients with Chronic Hepatitis C Infection

Efficacy of Sofosbuvir Plus Ribavirin with and without Pegylated Interferon in Management of Egyptian Chronic Hepatitis C Patients